Status:

COMPLETED

New Medication Treatment for Stimulant Dependence

Lead Sponsor:

University of Virginia

Collaborating Sponsors:

National Institute on Drug Abuse (NIDA)

Conditions:

Cocaine Dependence

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

This study will evaluate the efficacy of ondansetron compared with placebo in the treatment of cocaine dependence.

Detailed Description

We propose to conduct a 9 week randomized, controlled clinical trial to evaluate the efficacy of ondansetron 4 mg twice daily compared with placebo (total N = 100/group × 2 groups = 200 individuals ra...

Eligibility Criteria

Inclusion

  • Males and females who have given written informed consent.
  • Ages 18 years and above and, must weigh at least 40 Kg and no more than 140 Kg.
  • Good physical health as determined by a complete physical examination, an EKG within normal limits, and laboratory screening tests within acceptable parameters.
  • Current DSM-IV diagnosis of cocaine dependence.
  • At least one positive urine drug screen for cocaine at screen or baseline prior to randomization.
  • The pregnancy test for females at intake must be negative.
  • Literacy in English and ability to read, understand, and complete the ratings scales and questionnaires accurately, follow instructions, and make use of the behavioral treatments.
  • Answered an advertisement in the newspaper/radio/television, and expressing a wish to stop using cocaine.
  • Willing to participate in behavioral treatments for cocaine dependence.

Exclusion

  • Please contact site for additional information

Key Trial Info

Start Date :

July 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2013

Estimated Enrollment :

108 Patients enrolled

Trial Details

Trial ID

NCT00689572

Start Date

July 1 2008

End Date

December 1 2013

Last Update

November 11 2021

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

University of Virginia Center for Addiction Research and Education

Charlottesville, Virginia, United States, 22911

2

University of Virginia Center for Addiction Research and Education

Richmond, Virginia, United States, 23294

New Medication Treatment for Stimulant Dependence | DecenTrialz